1. Disease Areas
  2. Urogenital Disease
  3. Male Reproductive System Disease

Male Reproductive System Disease

Male reproductive system disease encompasses a range of disorders affecting organs and functions involved in male fertility and sexual health, including erectile dysfunction, premature ejaculation, low libido, testicular lumps, prostate disease, and infertility. These conditions may arise from physiological factors such as aging, kidney failure, and medication use (e.g., antidepressants), as well as psychological factors like stress and anxiety. Symptoms can include testicular pain, perineal discomfort, nipple discharge, and difficulties with sexual performance or conception. Genetic factors, such as variants in the MIR199A1 gene, and pathways involving p53 regulation and immune response may contribute to disease development. The prostate and bone are commonly affected tissues, and treatments may involve hormonal agents like progesterone and dydrogesterone. Early recognition and medical evaluation are crucial for effective management.

Male Reproductive System Disease (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-W724254
    SNAP-6201 252201-38-0
    SNAP-6201 is a selective α1a adrenoceptor antagonist with a Ki of 0.2 nM. SNAP-6201 exhibits >1400-fold selectivity over α1b and α1d adrenoceptors. SNAP-6201 exhibits excellent selectively to inhibit intraurethral pressure (IUP) in the anesthetized dog model. SNAP-6201 can be used for benign prostatic hyperplasia (BPH) research.
    SNAP-6201